✦ New CED Clinical Relevance #78 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. NeurologyResearchAging Why This Matters Clinicians should be aware that emerging evidence suggests cannabis use may...
The Florida Cannabis Debate Will Still Be Around
✦ New CED Clinical Relevance #45 Clinical Context Background information relevant to the evolving cannabis medicine landscape. AgingSleepPainResearchPolicy Why This Matters Clinicians need to understand the growing population of older adults self-treating...
Medical cannabis can play key role in UK mental health crisis – leafie
✦ New CED Clinical Relevance #45 Clinical Context Background information relevant to the evolving cannabis medicine landscape. Mental HealthResearchPolicyAging Clinical Summary This article discusses emerging evidence that medical cannabis may address the...
How cannabis is reshaping the menopause conversation | GreenState
✦ New CED Clinical Relevance #65 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. AgingCBDResearchAnxietySleep Why This Matters Clinicians treating menopausal patients need evidence-based information about cannabis efficacy for...
Cannabis Compounds Show Promise Against Fatty Liver Disease | NewsGhana
✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchCBDHealth ScienceAging Why This Matters Cannabis and Fatty Liver Disease: Clinical RelevanceClinicians need to understand...
Daily Digest: Last 2 Hours: Stroke Risk, Industry Maturation, and Reassurance for Older Adults — March 09, 2026
A synthesis of 9 recently added cannabis articles — key themes, clinical context, and Dr. Caplan’s take.
Study: Cannabis use among older adults does not accelerate mental decline
✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. AgingMental HealthNeurologyResearch Why This Matters This finding is clinically relevant because it challenges assumptions that...
Cannabis Compounds CBD and CBG Show Promise in Reducing Liver Fat and Improving …
✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. ResearchCBDHempAgingSafety Why This Matters Clinicians treating patients with non-alcoholic fatty liver disease or metabolic dysfunction-associated...
Daily Digest: Last 24 Hours: Cannabinoids and Liver Disease Lead a Busy News Cycle — March 07, 2026
Last 24 Hours March 07, 2026 — 52 articles reviewed This cycle was dominated by widespread coverage of preclinical research showing cannabinoids may combat fatty liver disease, alongside a cluster of state-level...
Study reveals cannabis compounds reduce threat of fatty liver disease | Health – News-Topic
WHY IT MATTERS: For the millions of patients with fatty liver disease who have limited pharmacological options, cannabinoid-based therapies could represent a meaningful new direction in treatment if ongoing clinical trials confirm these early findings. CLINICAL OVERVIEW: Emerging research suggests that cannabinoids, including both THC and CBD, may play a protective role against the development and progression of non-alcoholic fatty liver disease (NAFLD) by modulating hepatic inflammation, lipid metabolism, and fibrotic pathways through the endocannabinoid system. The liver expresses both CB1 and CB2 receptors, and while CB1 activation has historically been associated with pro-steatotic effects, selective CB2 stimulation appears to confer anti-inflammatory and antifibrotic benefits.